Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer | MicrobiomeTrials← Back to trialsNCT01174121
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2010-08-26Est. Completion: 2028-12-27
Enrollment target: 332 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Advanced/Metastatic Colorectal Adenocarcinoma
Researchers are looking for a better way to treat people who have advanced or metastatic colorectal cancer (CRC) with a …
Phoenix, United StatesEst. completion Jul 27, 2029
Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaMetastatic Anal Squamous Cell CarcinomaRecurrent Anal Squamous Cell CarcinomaStage III Anal Cancer AJCC v8Stage IV Anal Cancer AJCC v8
Unresectable Anal Squamous Cell Carcinoma
This phase 3 trial compares the addition of nivolumab to chemotherapy (carboplatin and paclitaxel) versus usual treatmen…
Anchorage, United StatesEst. completion Mar 31, 2027
Colon AdenocarcinomaRectal Adenocarcinoma
Researchers are looking for other ways to treat locally advanced or metastatic colorectal cancer (mCRC) that is unresect…
Los Angeles, United StatesEst. completion Mar 28, 2029